首页
登录
职称英语
Doctors at Stanford University are studying a medication they hope will alle
Doctors at Stanford University are studying a medication they hope will alle
游客
2025-04-22
34
管理
问题
Doctors at Stanford University are studying a medication they hope will alleviate the suffering of millions of American women. But their target isn’t breast cancer, osteoporosis, or a similarly well-known affliction. Despite its alarming impact on its victims, the malady in question has received comparatively little medical scrutiny. It’s a "hidden epidemic," according to the Stanford researchers: compulsive shopping disorder.
That’s right. What was once merely a punchline in television sitcoms is now being taken seriously by many clinicians. According to the Stanford study’s leader, Dr. Lorrin Koran, compulsive shopping is "motivated by ’irresistible’ impulses, characterized by spending that is excessive and inappropriate, has harmful consequences for the individual, and tends to be chronic and stereotyped." Compulsive shoppers "binge buy" --most often clothes, shoes, makeup, and jewelry--and then suffer intense guilt. That, in turn, helps trigger another frenzied trip to the mall, and the cycle continues.
Could compulsive shopping be a health hazard associated with America’s unparalleled economic prosperity? "It seems to be a disease of affluence," says Dr. Jerrold Pollak, a clinical psychologist who’s treated several shopaholics. "Advertisers... would like us to think that shopping is a reason to live," agrees Dr. Cheryl Carmin, another clinical psychologist. "If you do not have the time or inclination to go to the mall or grocery store, there are catalogs, delivery services, home shopping networks on TV, and endless items to buy via the Internet." Indeed, this year, US advertisers will spend $ 233 billion--an amount equal to six federal education budgets to persuade Americans to buy, buy, buy.
Yet the possibility that US advertisers may be driving certain women in our society t9 psychosis is only part of the story. It seems that the pharmaceutical companies’ quest to cure the effects of excessive marketing may itself be little more than a cleverly-disguised marketing scheme. The Stanford study, like many of its kind, is being funded by a pharmaceutical company. The undisclosed drug is an FDA-approved antidepressant, specifically an SSRI--a selective serotonin re-uptake inhibitor. (The researchers are also studying behavioral therapies for compulsive shoppers.)
The researchers running the Stanford study refused to reveal their sponsor. However, only five SSRIs are currently on the US market. Pfizer (makers of Zolofi), Eli Billy (Prozac) and SmithKline Beecham (Paxil) all reported that they are neither conducting nor planning any studies of their drugs for compulsive shopping. Solvay (Luvox)also seems an unlikely candidate. In 1997, researchers at the University of Iowa tried using Luvox to treat compulsive shoppers and found no measurable differences between the effects of the drug and those of a placebo. Perhaps the manufacturers of Luvox want to give their product another shot. More likely, however, the mysterious benefactor of the Stanford Study is Forest Pharmaceuticals (Celexa). Their PR department neither confirmed nor denied any involvement in Koran’s study.
Why would a pharmaceutical company anonymously spend money to license one of its top-selling drugs for a marginal disorder like compulsive shopping? A big part of the answer is profit. The mystery company presumably hopes to carve a unique slice out of the mental disorder pie in order to market it together with a ready-made treatment. This is not at all a new strategy for the world’s mammoth pharmaceutical firms, as David Healy, a professor at the University of Wales College of Medicine, explains in his book "The Anti- Depressant Em." Healy’s book describes a process by which companies Seek to "educate" both patients and clinicians about a new disorder, to sell the disorder in preparation for selling its cure. Funding clinical trials is a crucial part of that process. [br] The author would most likely agree with which of the following statements?
选项
A、Advertising is responsible for compulsive shopping disorder.
B、Pharmaceutical companies counteract the effects of advertisers who persuade Americans to binge buy.
C、Pharmaceutical companies are to blame for compulsive shopping disorder.
D、Pharmaceutical companies are every bit as marketing-oriented as advertisers.
答案
D
解析
该题要求理解作者在文章的后半部分所讨论的主要内容。在第四段开始作者就指出,并不仅仅是广告商们有可能对不由自主的购物行为负责:制药公司的做法本身就是一种伪装巧妙的营销策略。因此D项为正确答案。
转载请注明原文地址:https://tihaiku.com/zcyy/4048873.html
相关试题推荐
DoctorsatStanfordUniversityarestudyingamedicationtheyhopewillalle
DoctorsatStanfordUniversityarestudyingamedicationtheyhopewillalle
Therearemanygoodreasonsforgreatcurrentattentiontouniversity-indust
Therearemanygoodreasonsforgreatcurrentattentiontouniversity-indust
Therearemanygoodreasonsforgreatcurrentattentiontouniversity-indust
Thecandidatehascompliedwithalltherequirementssetbytheuniversity;this
UniversityPhysicsisintendedforstudentsofscienceandengineering.Pri
UniversityPhysicsisintendedforstudentsofscienceandengineering.Pri
UniversityPhysicsisintendedforstudentsofscienceandengineering.Pri
UniversityPhysicsisintendedforstudentsofscienceandengineering.Pri
随机试题
Thedriestcontinentsis______[br][originaltext]LECTURERGoodmorning.Thism
[originaltext]W:Tony,wouldyouliketogoswimmingwithus?M:Thanks,buti
MostofRussia’ssuper-richspendtheirsummerholidaysonyachtsinthesu
( )不属于针对UTP(非屏蔽双绞线)测试内容。A.接线图 B.近端干扰
女,40岁,反复右上腹绞痛20年,发作时伴有寒战、高热及皮肤巩膜黄染。2天前再次
证券公司股东的出资,应当经具有证券、期货相关业务资格的()并出具证明。A.会计
泰山磐石散与参苓白术散的共同药物是A.白术、砂仁 B.人参、黄芪 C.淮山药
银行承兑汇票的承兑银行,应当按照票面金额向出票人收取()的手续费。A:千分之一
图示结构,AC为铝杆,AAC=200mm2,lAC=2.5m,EAC=70GPa
对于钛及钛合金性能描述正确的是()。A.具有良好的低温性能 B.耐硝酸和碱溶
最新回复
(
0
)